You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Refractory Pediatric Solid Tumor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Osteosarcoma, Ewing Sarcoma, Rhabdomyosarcoma Trial in Washington (Cryoablation Therapy, Nivolumab, Ipilimumab)

Recruiting
  • Osteosarcoma
  • +9 more
  • Cryoablation Therapy
  • +2 more
  • Washington, District of Columbia
    Children's National Hospital
Mar 21, 2022

Refractory Cancer, CNS Tumors, CNS Tumor, Adult Trial in Atlanta, New York (Avutometinib)

Recruiting
  • Refractory Cancer
  • +14 more
  • Atlanta, Georgia
  • +1 more
Oct 23, 2023

Refractory Solid Tumor, Hepatocellular Carcinoma, Malignant Solid Tumor Trial in Memphis (Atezolizumab, Sorafenib, Bevacizumab)

Recruiting
  • Refractory Solid Tumor
  • +4 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 4, 2022

Solid Tumor Trial in Dallas (Atezolizumab, Vincristine, Irinotecan)

Not yet recruiting
  • Solid Tumor
  • Dallas, Texas
    The University of Texas Southwestern Medical Center
Aug 30, 2022

Relapsed Pediatric Solid Tumors, Refractory Pediatric Solid Tumors, Rhabdomyosarcoma Trial in Washington, Cincinnati (Magnetic

Active, not recruiting
  • Relapsed Pediatric Solid Tumors
  • +9 more
  • Magnetic Resonance High Intensity Focused Ultrasound
  • Washington, District of Columbia
  • +1 more
Jan 21, 2022

Wilms Tumor, Rhabdoid Tumor, Malignant Peripheral Nerve Sheath Tumors Trial in United States (Selinexor)

Recruiting
  • Wilms Tumor
  • +6 more
  • Los Angeles, California
  • +10 more
Aug 2, 2023

Desmoplastic Small Round Cell Tumor, Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Desmoplastic Small

Recruiting
  • Desmoplastic Small Round Cell Tumor
  • +11 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 26, 2022

Primary Extra-cranial Solid Tumor, Recurrent or Refractory Glypican 3 (GPC3) Trial in New York, Cincinnati (Codrituzumab)

Recruiting
  • Primary Extra-cranial Solid Tumor
  • Recurrent or Refractory Glypican 3 (GPC3)
  • Los Angeles, California
  • +2 more
Oct 28, 2022

Pediatric Solid Tumor, Germ Cell Tumor, Retinoblastoma Trial in Seattle (second generation 4-1BB? EGFR806-EGFRt, second

Recruiting
  • Pediatric Solid Tumor
  • +15 more
  • second generation 4-1BBζ EGFR806-EGFRt
  • second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
  • Seattle, Washington
    Seattle Children's Hospital
May 2, 2022

Transitional Cell Tumor, Hepatoblastoma, Liver Cancer Trial in Shanghai (PD-1 inhibitor)

Not yet recruiting
  • Transitional Cell Tumor
  • +4 more
  • PD-1 inhibitor
  • Shanghai, China
    Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
Apr 3, 2022

Solid Tumor, Lymphoma, Osteosarcoma Trial in Orange (Surufatinib in combination with Gemcitabine)

Recruiting
  • Solid Tumor
  • +5 more
  • Surufatinib in combination with Gemcitabine
  • Orange, California
    Childrens Hospital Orange County
Feb 8, 2022

Melanoma, Lymphoma, Solid Tumor Trial in Worldwide (Pembrolizumab)

Recruiting
  • Melanoma
  • +4 more
  • Pembrolizumab
  • Aurora, Colorado
  • +18 more
Jan 5, 2023

Pediatric Cancer, Solid Tumors, Rhabdomyosarcoma Trial in Washington (Magnetic resonance high intensity focused ultrasound,

Recruiting
  • Pediatric Cancer
  • +9 more
  • Magnetic resonance high intensity focused ultrasound
  • Lyso-thermosensitive liposomal doxorubicin
  • Washington, District of Columbia
    Children's National Medical Center
Dec 10, 2021

Refractory or Recurrent Solid Tumor Trial in France (Spartalizumab in Pediatric cohort, Low-dose Pazopanib in Pediatric Cohort,

Not yet recruiting
  • Refractory or Recurrent Solid Tumor
  • Spartalizumab in Pediatric cohort
  • +3 more
  • Angers, France
  • +8 more
Mar 9, 2022

Relapsed Solid Tumor, Refractory Solid Tumor, Relapsed CNS Tumor Trial in United States (cemiplimab (monotherapy), cemiplimab

Recruiting
  • Relapsed Solid Tumor
  • +5 more
  • cemiplimab (monotherapy)
  • +3 more
  • Los Angeles, California
  • +19 more
Jan 27, 2022

Neuroblastoma, Pediatric Solid Tumor Trial in Boston (procedure, biological, drug)

Recruiting
  • Neuroblastoma
  • Pediatric Solid Tumor
  • Tissue collection
  • +3 more
  • Boston, Massachusetts
  • +1 more
Oct 17, 2022

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Hodgkin Lymphoma Trial in Madison (TCRaß+/CD19+ depleted Haploidentical

Recruiting
  • Acute Myeloid Leukemia
  • +10 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Mar 1, 2022

Neuroblastoma, Rhabdomyosarcoma, Osteosarcoma Trial in United States (Enoblituzumab)

Completed
  • Neuroblastoma
  • +5 more
  • Palo Alto, California
  • +5 more
Feb 4, 2022

Mixed Tumor, Malignant Trial in United States (BAY806946)

Recruiting
  • Mixed Tumor, Malignant
  • Birmingham, Alabama
  • +20 more
Jan 20, 2023

Cancer, Pediatric Solid Tumor, Pediatric AML Trial in Australia, United Kingdom (PEG- BCT-100)

Completed
  • Cancer
  • +3 more
  • PEG- BCT-100
  • Adelaide, Australia
  • +13 more
Sep 1, 2022

Pediatric Cancer, Hodgkin Disease, CD30-Positive DLBCL Trial in Milwaukee (anti-CD30 Bispecific Antibody-armed

Not yet recruiting
  • Pediatric Cancer
  • +11 more
  • anti-CD30 Bispecific Antibody-armed anti-CD3-Activated Autologous T-cells (CD30 biAb-AATC)
  • Milwaukee, Wisconsin
    Children's Wisconsin
Sep 14, 2022

Relapsed Solid Tumor, Refractory Solid Tumor Trial in Worldwide (Abemaciclib, Irinotecan, Temozolomide)

Recruiting
  • Relapsed Solid Tumor
  • Refractory Solid Tumor
  • Phoenix, Arizona
  • +28 more
Dec 7, 2022

Pediatric Solid Tumor, Pediatric Lymphoma, Pediatric Brain Tumor Trial in Australia, Canada, United States (CLR 131)

Recruiting
  • Pediatric Solid Tumor
  • +7 more
  • CLR 131
  • Palo Alto, California
  • +6 more
Nov 30, 2021

Neuroblastoma, Solid Tumor Trial (APG-115, APG-2575)

Not yet recruiting
  • Neuroblastoma
  • Solid Tumor
  • (no location specified)
Jan 18, 2023

Solid Tumor, Leukemia Trial in Paris (Solid tumor and CT DNA)

Recruiting
  • Solid Tumor
  • Leukemia
  • Solid tumor and CT DNA
  • Paris, Villejuif, France
    Gustave Roussy
Jan 19, 2023